142 related articles for article (PubMed ID: 25497252)
1. Sex, adverse cardiac events, and infarct size in anterior myocardial infarction: an analysis of intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction (INFUSE-AMI).
Tomey MI; Mehran R; Brener SJ; Maehara A; Witzenbichler B; Dizon JM; El-Omar M; Xu K; Gibson CM; Stone GW
Am Heart J; 2015 Jan; 169(1):86-93. PubMed ID: 25497252
[TBL] [Abstract][Full Text] [Related]
2. Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial.
Brener SJ; Maehara A; Dizon JM; Fahy M; Witzenbichler B; Parise H; El-Omar M; Dambrink JH; Mehran R; Oldroyd K; Gibson CM; Stone GW
JACC Cardiovasc Interv; 2013 Jul; 6(7):718-24. PubMed ID: 23866184
[TBL] [Abstract][Full Text] [Related]
3. Impact of delay to reperfusion on reperfusion success, infarct size, and clinical outcomes in patients with ST-segment elevation myocardial infarction: the INFUSE-AMI Trial (INFUSE-Anterior Myocardial Infarction).
Guerchicoff A; Brener SJ; Maehara A; Witzenbichler B; Fahy M; Xu K; Gersh BJ; Mehran R; Gibson CM; Stone GW
JACC Cardiovasc Interv; 2014 Jul; 7(7):733-40. PubMed ID: 25060015
[TBL] [Abstract][Full Text] [Related]
4. Effect of Smoking on Infarct Size and Major Adverse Cardiac Events in Patients With Large Anterior ST-Elevation Myocardial Infarction (from the INFUSE-AMI Trial).
Gennaro G; Brener SJ; Redfors B; Kirtane AJ; Généreux P; Maehara A; Neunteufl T; Metzger DC; Mehran R; Gibson CM; Stone GW
Am J Cardiol; 2016 Oct; 118(8):1097-1104. PubMed ID: 27553094
[TBL] [Abstract][Full Text] [Related]
5. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial.
Stone GW; Maehara A; Witzenbichler B; Godlewski J; Parise H; Dambrink JH; Ochala A; Carlton TW; Cristea E; Wolff SD; Brener SJ; Chowdhary S; El-Omar M; Neunteufl T; Metzger DC; Karwoski T; Dizon JM; Mehran R; Gibson CM;
JAMA; 2012 May; 307(17):1817-26. PubMed ID: 22447888
[TBL] [Abstract][Full Text] [Related]
6. Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial.
Brener SJ; Witzenbichler B; Maehara A; Dizon J; Fahy M; El-Omar M; Dambrink JH; Genereux P; Mehran R; Oldroyd K; Parise H; Gibson CM; Stone GW
Am Heart J; 2013 Jul; 166(1):64-70. PubMed ID: 23816023
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction.
Gibson CM; Maehara A; Lansky AJ; Wohrle J; Stuckey T; Dave R; Cox D; Grines C; Dudek D; Steg G; Parise H; Wolff SD; Cristea E; Stone GW
Am Heart J; 2011 Mar; 161(3):478-486.e7. PubMed ID: 21392601
[TBL] [Abstract][Full Text] [Related]
8. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial.
Eitel I; Wöhrle J; Suenkel H; Meissner J; Kerber S; Lauer B; Pauschinger M; Birkemeyer R; Axthelm C; Zimmermann R; Neuhaus P; Brosteanu O; de Waha S; Desch S; Gutberlet M; Schuler G; Thiele H
J Am Coll Cardiol; 2013 Apr; 61(13):1447-54. PubMed ID: 23466078
[TBL] [Abstract][Full Text] [Related]
9. Relation between white blood cell count and final infarct size in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the INFUSE AMI trial).
Palmerini T; Brener SJ; Genereux P; Maehara A; Della Riva D; Mariani A; Witzenbichler B; Godlewski J; Parise H; Dambrink JH; Ochala A; Fahy M; Xu K; Gibson CM; Stone GW
Am J Cardiol; 2013 Dec; 112(12):1860-6. PubMed ID: 24063843
[TBL] [Abstract][Full Text] [Related]
10. Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the INFUSE-AMI trial).
Dohi T; Maehara A; Brener SJ; Généreux P; Gershlick AH; Mehran R; Gibson CM; Mintz GS; Stone GW
Am J Cardiol; 2015 Mar; 115(5):563-70. PubMed ID: 25586335
[TBL] [Abstract][Full Text] [Related]
11. Intralesional abciximab and thrombus aspiration in patients with large anterior myocardial infarction: one-year results from the INFUSE-AMI trial.
Stone GW; Witzenbichler B; Godlewski J; Dambrink JH; Ochala A; Chowdhary S; El-Omar M; Neunteufl T; Metzger DC; Dizon JM; Wolff SD; Brener SJ; Mehran R; Maehara A; Gibson CM
Circ Cardiovasc Interv; 2013 Oct; 6(5):527-34. PubMed ID: 24084626
[TBL] [Abstract][Full Text] [Related]
12. Outcomes in diabetic patients undergoing primary percutaneous coronary intervention for acute anterior myocardial infarction: results from the INFUSE-AMI study.
Sanidas EA; Brener SJ; Maehara A; Généreux P; Witzenbichler B; El-Omar M; Fahy M; Mehran R; Gibson CM; Stone GW
Catheter Cardiovasc Interv; 2014 Apr; 83(5):704-10. PubMed ID: 24030863
[TBL] [Abstract][Full Text] [Related]
13. Relationship between ST-segment resolution and anterior infarct size after primary percutaneous coronary intervention: analysis from the INFUSE-AMI trial.
Dizon JM; Brener SJ; Maehara A; Witzenbichler B; Biviano A; Godlewski J; Parise H; Dambrink JH; Mehran R; Gibson CM; Stone GW
Eur Heart J Acute Cardiovasc Care; 2014 Mar; 3(1):78-83. PubMed ID: 24562806
[TBL] [Abstract][Full Text] [Related]
14. Randomized evaluation of intralesion versus intracoronary abciximab and aspiration thrombectomy in patients with ST-elevation myocardial infarction: The COCTAIL II trial.
Prati F; Romagnoli E; Limbruno U; Pawlowski T; Fedele S; Gatto L; Di Vito L; Pappalardo A; Ramazzotti V; Picchi A; Trivisonno A; Materia L; Pfiatkosky P; Paoletti G; Marco V; Tavazzi L; Versaci F; Stone GW
Am Heart J; 2015 Dec; 170(6):1116-23. PubMed ID: 26678633
[TBL] [Abstract][Full Text] [Related]
15. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of the Left Anterior Descending Artery Wrapping Around the Left Ventricular Apex to Predict Adverse Clinical Outcomes in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction (an INFUSE-AMI Substudy).
Kobayashi N; Maehara A; Mintz GS; Wolff SD; Généreux P; Xu K; Mehran R; Gibson CM; Brener SJ; Stone GW
Am J Cardiol; 2015 May; 115(10):1389-95. PubMed ID: 25770973
[TBL] [Abstract][Full Text] [Related]
17. In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program.
Hassan AK; Liem SS; van der Kley F; Bergheanu SC; Wolterbeek R; Bosch J; Bootsma M; Zeppenfeld K; van der Laarse A; Atsma DE; Jukema JW; Schalij MJ
Catheter Cardiovasc Interv; 2009 Aug; 74(2):335-43. PubMed ID: 19642182
[TBL] [Abstract][Full Text] [Related]
18. Aspiration thrombectomy during primary percutaneous coronary intervention as adjunctive therapy to early (in-ambulance) abciximab administration in patients with acute ST elevation myocardial infarction: an analysis from Leiden MISSION! acute myocardial infarction treatment optimization program.
Ahmed TA; Atary JZ; Wolterbeek R; Hasan-Ali H; Abdel-Kader SS; Schalij MJ; Jukema JW
J Interv Cardiol; 2012 Feb; 25(1):1-9. PubMed ID: 22059390
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of standard versus ClearWay-infused abciximab and thrombectomy in myocardial infarction: rationale and design of the COCTAIL II study.
Prati F; Di Vito L; Ramazzotti V; Imola F; Pawlowski T; Materia L; Tavazzi L; Biondi-Zoccai G; Albertucci M
J Cardiovasc Med (Hagerstown); 2013 May; 14(5):364-71. PubMed ID: 22929568
[TBL] [Abstract][Full Text] [Related]
20. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
Thiele H; Schindler K; Friedenberger J; Eitel I; Fürnau G; Grebe E; Erbs S; Linke A; Möbius-Winkler S; Kivelitz D; Schuler G
Circulation; 2008 Jul; 118(1):49-57. PubMed ID: 18559698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]